Melanie Szweras and Patrick Roszell talk AI and Health Privacy with Lexpert
Recently Smart & Biggar Principals Patrick Roszell and Melanie Szweras sat down with Lexpert’s Zena Olijnyk to discuss the privacy impacts caused by the increasing use of artificial intelligence (AI) in the healthcare sector.
Melanie raised a few key privacy concerns, including the fact the someone’s “highly sensitive” health information could be improperly disclosed or misused, and whether data used in the health and life sciences sector has been properly anonymized. Of these concerns she notes “the key issue becomes the balance between the duty to protect personal health information and the ability to manage information in the healthcare system.”
Patrick discussed the touchpoints data has between acquisition and use and how parties along the way seek to impose restrictions or assert rights on how the data is used, noting “organizations are going to need to become more sophisticated about how they understand the importance of these rights, and how they contract around them.” He also noted that organizations need to understand both the technical aspects and the privacy considerations and that “technically-minded lawyers can do a lot to bring valuable guidance in connecting these dots.”
Read the full Lexpert interview.
Related News & Media
-
Reshika Dhir examines Canadian IP retention in TheFutureEconomy.ca
Principal Reshika Dhir recently wrote a piece featured in TheFutureEconomy.ca exploring a growing challenge in Canada’s innovation economy: the quiet migration of valuable intellectual property to ot...Read More -
Principals Noel Courage and Ainslie Parsons explore strategies for protecting new plant varieties across key markets
Principals Ainslie Parsons and Noel Courage, along with expert international coauthors, recently contributed to an article in The Patent Lawyer Magazine examining how plant breeders and biotechs can p...Read More -
Janice Bereskin and Tamara Céline Winegust discuss a key trademark ruling in Canada for the Pharmaceutical Trade Marks Group
Principals Janice Bereskin and Tamara Céline Winegust recently wrote a feature for the March 2026 edition of Spotlight from the Pharmaceutical Trade Marks Group, exploring the implications of the rece...Read More
